• Home
  • Pharma Bavaria International GmbH

Pharma Bavaria International GmbH

About Pharma Bavaria International GmbH

Pharma Bavaria International (Germany), markets highest-German/EU-quality pharmaceutical brands with well-researched ingredients in > 40 countries. In line with our vision: Access to Quality Healthcare we offer our products in emerging economies in MENA,  Asia, CIS and LATAM. Our Rx portfolio is being constantly expanded by OTC products and medical devices.  

Read more Show less
Certifications
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Germany
  • On CPHI since:
    2018
  • Certificates:
    1
  • Employees:
    25 - 49
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
Show contact info Hide contact info

Products from Pharma Bavaria International GmbH (3)

  • Parafusiv™ I.V. | Vitopeine™ I.V. (Paracetamol 10 mg/ml; 100 ml ● 50 ml)

    Product Parafusiv™ I.V. | Vitopeine™ I.V. (Paracetamol 10 mg/ml; 100 ml ● 50 ml)

    Vitopeine™ is indicated for the short-term treatment of moderate pain, especially following surgery & treatment of fever, when administration by intravenous routeis clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.
    ...
  • Tafixyl™ I.V. (Tranexamic acid 100 mg/ml; 5 ml ● 10 ml)

    Product Tafixyl™ I.V. (Tranexamic acid 100 mg/ml; 5 ml ● 10 ml)

    Prevention and treatment of bleeding due to local or general fibrinolysis in adults and children 1 year of age and older. Specific indications should be consulted in the SmPC.
    Brand names/trademarks might be subject to local/regional adaption. Indication for use might differ due to local requirem...
  • Zolimetax™ I.V. (Zoledronic acid 4 mg/5 ml ● 4 mg/100 ml)

    Product Zolimetax™ I.V. (Zoledronic acid 4 mg/5 ml ● 4 mg/100 ml)

    Prevention of skeletal-related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in patients with advanced malignancies involving bone. Treatment of tumour-induced ypercalcaemia.
    Brand names/trademarks might be subject to local...